NBIX ▼ -0.3% - Neurocrine Biosciences, Inc.
$NBIX NBIX - Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference
30-SEP-2026 08:31 AM ET
Share this post
More filings for $NBIX
NBIX ▲ +0.7% - Neurocrine Biosciences, Inc.Sep 2, 2026$NBIX SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026
View full $NBIX filing history →💬 Comments
Loading comments…
Leave a comment
